Shares of Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) were up 0.3% during mid-day trading on Wednesday . The stock traded as high as $1.9181 and last traded at $1.9160. Approximately 10,184 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 20,954 shares. The stock had previously closed at $1.91.
Ainos Stock Performance
The stock has a market capitalization of $9.22 million, a P/E ratio of -2.20 and a beta of 2.45. The company has a current ratio of 1.92, a quick ratio of 1.45 and a debt-to-equity ratio of 0.08. The company has a 50-day moving average price of $2.12 and a two-hundred day moving average price of $2.94.
Ainos Company Profile
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
Recommended Stories
- Five stocks we like better than Ainos
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
